BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Dronedarone

Increased Risk of Death, Stroke and Heart Failure in Patients with Decompensated Heart Failure or Permanent Atrial Fibrillation

  • In patients with symptomatic heart failure and recent decompensation requiring hospitalization or NYHA Class IV heart failure; dronedarone doubles the risk of death. 
  • Dronedarone is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure.
  • In patients with permanent atrial fibrillation, dronedarone doubles the risk of death, stroke and hospitalization for heart failure.
  • Dronedarone is contraindicated in patients in atrial fibrillation (AF) who will not or cannot be cardioverted into normal sinus rhythm.

Patient Counseling Information

Medication Guides

Patient Medication Guide

Package Inserts

Multaq

Updated January 2018